CROSBY Research – Suntien Green Energy (956 HK/BUY): NG/Wind NP down by 48%/8% YoY
04 Sep 2023 1H23 revenue was down by 1.7% YoY to Rmb10.0bn, mainly due to...
CROSBY Research – NFI (1837 HK/BUY): New channel business continued its growth momentum with 8,135 POS
31 Aug 2023 NFI’s 1H23 revenue was up by 4.0% YoY to Rmb874m. Offline channel...
CROSBY Research – IGG (799 HK/BUY): Multiple growth drivers from Doomsday, Viking Rise, and App business
30 Aug 2023 IGG announced 1H23 results with revenue edged up by 0.5% YoY to...
CROSBY Research – China Lesso (2128 HK/BUY): A resilient set of 1H23 results
29 Aug 2023 Despite the market uncertainties coupled with gloomy property sector in China in...
CROSBY Research – Wasion Holdings (3393 HK/BUY): A solid set of 1H23 results, indicating a good FY23
28 Aug 2023 Wasion’s 1H23 turnover increased by 26.4% YoY to Rmb3.2 bn while NP...
CROSBY Research – Sunny Optical (2382 HK/BUY): HLS/HCM shipment bottom out and sequential GPM improvement in 2H23
28 Aug 2023 Sunny reported 1H23 revenue decreased by 15.9% YoY to Rmb14,279m, dragged by...
CROSBY Research – Anta (2020 HK/BUY): Solid 1H23 results with expanding OPM
25 Aug 2023 Anta’s 1H23 revenue was up by 14.2% YoY to Rmb29.65bn, mainly driven...
CROSBY Research – Canvest (1381 HK/BUY): Higher revenue contribution from operation segment
25 Aug 2023 1H23 revenue down by 28% YoY to HK$2.98bn, mainly due to i)...
CROSBY Research – Xtep (1368 HK/BUY): Solid 1H23 revenue growth, full year sales growth target 15-20% YoY
24 Aug 2023 Xtep’s 1H23 revenue was up by 14.8% YoY to Rmb6,522m, mainly driven...
CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23
24 Aug 2023 In 1H23, Vincent Medical’s (VM) sales increased by 28.7% YoY to HK$361.2m...
CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings
22 Aug 2023 The company reported a 6.4% YoY increase in topline to Rmb6,294m in...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)
21 Aug 2023 Hong Kong’s population has grown 2.1% on the year to almost 7.5...
CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23
18 Aug 2023 The company reported a 6.7% YoY increase in topline to Rmb1,491m in...
CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook
17 Aug 2023 1H23 revenue increased by 18.0% YoY to Rmb4.31bn, with core brand retail...
CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum
16 Aug 2023 Pentamaster’s 2Q23 revenue increased 16.8% YoY from MYR151.3m in 2Q22 to MYR176.8m...
CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment
15 Aug 2023 CEG’s 1H23 revenue was down by 9% YoY to HK$3,820m, driven by...
CROSBY Research – SIIC (807 HK): Growth driven by the new Baoshan project
14 Aug 2023 SIIC’s 1H23 revenue increased by 9.0% YoY to Rmb4.02bn, mainly driven by...
CROSBY Research – Q-Tech (1478 HK/BUY): Expect the recovery trajectory to maintain in 2H23, maintain BUY rating
11 Aug 2023 Q-Tech reported 1H23 revenue of Rmb5,477m, which decreased 22.8% YoY. 1H23 total...
CROSBY Research – TMT sector: Review of 2Q23 smartphone shipment and market share
07 Aug 2023 According to the latest data from IDC, despite global smartphone shipment contracted...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 40)
07 Aug 2023 Global/ China smartphone shipment decline narrowed in 2Q23. Transsion made into top...